DK2072041T3 - Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof - Google Patents
Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stofInfo
- Publication number
- DK2072041T3 DK2072041T3 DK08462008.7T DK08462008T DK2072041T3 DK 2072041 T3 DK2072041 T3 DK 2072041T3 DK 08462008 T DK08462008 T DK 08462008T DK 2072041 T3 DK2072041 T3 DK 2072041T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- film
- active substance
- coated tablets
- tablets containing
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title 1
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title 1
- 229960004845 drospirenone Drugs 0.000 title 1
- 239000007941 film coated tablet Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0700826A HUP0700826A3 (en) | 2007-12-20 | 2007-12-20 | Coated tablet containing drospirenone and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2072041T3 true DK2072041T3 (da) | 2012-11-05 |
Family
ID=89987951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08462008.7T DK2072041T3 (da) | 2007-12-20 | 2008-10-06 | Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof |
Country Status (23)
Country | Link |
---|---|
US (1) | US20110002993A1 (da) |
EP (2) | EP2072041B1 (da) |
JP (1) | JP5679819B2 (da) |
CN (1) | CN101896166B (da) |
AU (1) | AU2008339588B2 (da) |
BR (1) | BRPI0820450A2 (da) |
CA (1) | CA2708875A1 (da) |
CY (1) | CY1113416T1 (da) |
DK (1) | DK2072041T3 (da) |
EA (1) | EA017869B1 (da) |
ES (1) | ES2391953T3 (da) |
HK (1) | HK1147054A1 (da) |
HR (1) | HRP20120815T1 (da) |
HU (1) | HUP0700826A3 (da) |
IL (1) | IL205818A (da) |
MY (1) | MY148138A (da) |
NZ (1) | NZ585554A (da) |
PL (1) | PL2072041T3 (da) |
PT (1) | PT2072041E (da) |
SI (1) | SI2072041T1 (da) |
UA (1) | UA103182C2 (da) |
WO (1) | WO2009081216A1 (da) |
ZA (1) | ZA201003913B (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160048305A1 (en) * | 2014-08-14 | 2016-02-18 | Microsoft Corporation | Group-Based User Interface Rearrangement |
US10232045B2 (en) * | 2016-08-04 | 2019-03-19 | Bpsi Holdings Llc | Easy to swallow coatings and substrates coated therewith |
WO2019146788A1 (ja) * | 2018-01-29 | 2019-08-01 | Phcホールディングス株式会社 | バイオセンサプローブ用保護膜材料 |
EP3766421A4 (en) * | 2018-03-13 | 2021-12-15 | PHC Holdings Corporation | PROTECTIVE FILM MATERIAL FOR BIOSENSOR PROBE |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2652761C2 (de) | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE3022337A1 (de) | 1980-06-11 | 1982-01-07 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen |
DK1598069T3 (da) * | 1999-08-31 | 2009-07-06 | Bayer Schering Pharma Ag | Farmaceutisk præparat af ethinylestradiol og drospirenon til anvendelse som præventionsmiddel |
US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
EP1216713A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
JP2004315713A (ja) * | 2003-04-18 | 2004-11-11 | Shin Etsu Chem Co Ltd | 非イオン性セルロースエーテルの製造方法及びこれにより得られる非イオン性セルロースエーテル造粒物 |
EP1625849A1 (en) * | 2004-08-09 | 2006-02-15 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical composition comprising drospirenone and ethynylestradiol |
US8475838B2 (en) * | 2005-06-03 | 2013-07-02 | Sandoz Ag | Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
EP1767194A1 (de) * | 2005-06-09 | 2007-03-28 | Helm AG | Verfahren zur Herstellung von Adsorbaten des Drospirenons |
-
2007
- 2007-12-20 HU HU0700826A patent/HUP0700826A3/hu unknown
-
2008
- 2008-09-02 BR BRPI0820450-0A patent/BRPI0820450A2/pt not_active Application Discontinuation
- 2008-09-02 WO PCT/HU2008/000100 patent/WO2009081216A1/en active Application Filing
- 2008-09-02 NZ NZ585554A patent/NZ585554A/en unknown
- 2008-09-02 CN CN2008801205209A patent/CN101896166B/zh active Active
- 2008-09-02 AU AU2008339588A patent/AU2008339588B2/en active Active
- 2008-09-02 US US12/809,441 patent/US20110002993A1/en not_active Abandoned
- 2008-09-02 MY MYPI2010002356A patent/MY148138A/en unknown
- 2008-09-02 CA CA2708875A patent/CA2708875A1/en not_active Abandoned
- 2008-09-02 JP JP2010538923A patent/JP5679819B2/ja active Active
- 2008-09-02 UA UAA201009145A patent/UA103182C2/ru unknown
- 2008-09-02 EA EA201001032A patent/EA017869B1/ru unknown
- 2008-10-06 ES ES08462008T patent/ES2391953T3/es active Active
- 2008-10-06 EP EP08462008A patent/EP2072041B1/en not_active Revoked
- 2008-10-06 SI SI200830763T patent/SI2072041T1/sl unknown
- 2008-10-06 EP EP12151732A patent/EP2446880A1/en not_active Withdrawn
- 2008-10-06 PL PL08462008T patent/PL2072041T3/pl unknown
- 2008-10-06 PT PT08462008T patent/PT2072041E/pt unknown
- 2008-10-06 DK DK08462008.7T patent/DK2072041T3/da active
-
2010
- 2010-05-17 IL IL205818A patent/IL205818A/en active IP Right Grant
- 2010-06-01 ZA ZA2010/03913A patent/ZA201003913B/en unknown
-
2011
- 2011-02-01 HK HK11101080.6A patent/HK1147054A1/xx unknown
-
2012
- 2012-10-05 CY CY20121100930T patent/CY1113416T1/el unknown
- 2012-10-11 HR HRP20120815AT patent/HRP20120815T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
UA103182C2 (ru) | 2013-09-25 |
JP2011507825A (ja) | 2011-03-10 |
PL2072041T3 (pl) | 2012-12-31 |
HUP0700826A3 (en) | 2010-03-29 |
AU2008339588A1 (en) | 2009-07-02 |
JP5679819B2 (ja) | 2015-03-04 |
CY1113416T1 (el) | 2016-06-22 |
CA2708875A1 (en) | 2009-07-02 |
ZA201003913B (en) | 2011-03-30 |
NZ585554A (en) | 2012-06-29 |
EP2446880A1 (en) | 2012-05-02 |
IL205818A (en) | 2016-05-31 |
CN101896166A (zh) | 2010-11-24 |
US20110002993A1 (en) | 2011-01-06 |
MY148138A (en) | 2013-02-28 |
AU2008339588B2 (en) | 2014-06-26 |
HRP20120815T1 (hr) | 2012-11-30 |
SI2072041T1 (sl) | 2012-11-30 |
IL205818A0 (en) | 2010-11-30 |
ES2391953T3 (es) | 2012-12-03 |
EP2072041A1 (en) | 2009-06-24 |
HK1147054A1 (en) | 2011-07-29 |
PT2072041E (pt) | 2012-10-31 |
HUP0700826A2 (en) | 2009-07-28 |
WO2009081216A1 (en) | 2009-07-02 |
EP2072041B1 (en) | 2012-08-01 |
EA201001032A1 (ru) | 2010-12-30 |
CN101896166B (zh) | 2013-05-01 |
EA017869B1 (ru) | 2013-03-29 |
HU0700826D0 (en) | 2008-02-28 |
BRPI0820450A2 (pt) | 2015-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2346888T3 (da) | Fremgangsmåde til fremstilling af som SGLT-inhibitorer anvendelige forbindelser | |
DK2431359T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
DK2344198T3 (da) | Lipidbaserede farmaceutiske præparater til topisk anvendelse | |
DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
DK2114886T3 (da) | Fremgangsmåde til fremstilling af visse substituerede sulfiliminer | |
NO20090295L (no) | Substituerte heteroarylderivater | |
CL2007001040A1 (es) | Proceso para la preparacion de antagonista de la sustancia p derivado de acil-amino-alquilen-amida. | |
DK2462116T3 (da) | Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser | |
HK1160762A1 (zh) | 料盒、用於固體藥物部分的藥物分配器以及它們的使用 | |
PL2076244T3 (pl) | Układy wodne do wytwarzania związków farmaceutycznych na bazie lipidów; kompozycje, sposoby, oraz ich zastosowanie | |
DK2773633T3 (da) | Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf. | |
BRPI0906475A2 (pt) | Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto | |
MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
DK2658851T3 (da) | Heterocykliske forbindelser, som er egnede til behandling af dyslipidæmi | |
DK2107055T3 (da) | Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
AP2011005935A0 (en) | New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them. | |
EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
UA107476C2 (uk) | Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів | |
DK1843977T3 (da) | Fremgangsmåde til fremstilling af cæsiumhydroxidopløsninger | |
DK2281822T3 (da) | Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
DK2231598T3 (da) | Nye diazeniumdiolatderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK2471781T3 (da) | Benzylaralkylether-forbindelser, fremgangsmåde til fremstilling af samme, mel-lemproduktforbindelser, anvendelse af disse forbindelser, fremgangsmåde til behandling og/eller forebyggelse, farmaceutisk sammensætning og medikament, som indeholder samme. | |
DK2072041T3 (da) | Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof | |
BRPI1006758A2 (pt) | compostos fosfocálcicos dopados com gálio, processos em estado sólido e em solução para a fabricação de um composto fosfocálcico dopado com gálio e uso de um composto fosfocálcico dopado com gálio |